首页 | 本学科首页   官方微博 | 高级检索  
     


No evidence for association of ataxia-telangiectasia mutated gene T2119C and C3161G amino acid substitution variants with risk of breast cancer
Authors:Amanda?B?Spurdle  author-information"  >  author-information__contact u-icon-before"  >  mailto:mandyS@qimr.edu.au"   title="  mandyS@qimr.edu.au"   itemprop="  email"   data-track="  click"   data-track-action="  Email author"   data-track-label="  "  >Email author,John?L?Hopper,Xiaoqing?Chen,Margaret?RE?McCredie,Graham?G?Giles,Beth?Newman,Georgia?Chenevix-Trench,KumKum?Khanna
Affiliation:(1) Cancer and Cell Biology Division, The Queensland Institute of Medical Research, PO Royal Brisbane Hospital, Queensland, Australia;(2) Centre for Genetic Epidemiology, University of Melbourne, Victoria, Australiayy;(3) Cancer Epidemiology Research Unit, The New South Wales Cancer Council, Kings Cross, Australia;(4) Department of Preventive and Social Medicine, University of Otago, Dunedin, New Zealand;(5) Cancer Epidemiology Centre, The Cancer Council Victoria, Carlton, Victoria, Australia;(6) School of Public Health, Queensland University of Technology, Kelvin Grove, Queensland, Australia
Abstract:

Background  

There is evidence that certain mutations in the double-strand break repair pathway ataxia-telangiectasia mutated gene act in a dominant-negative manner to increase the risk of breast cancer. There are also some reports to suggest that the amino acid substitution variants T2119C Ser707Pro and C3161G Pro1054Arg may be associated with breast cancer risk. We investigate the breast cancer risk associated with these two nonconservative amino acid substitution variants using a large Australian population-based case–control study.
Keywords:
本文献已被 PubMed SpringerLink 等数据库收录!
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号